What you'll discover in this report
The Rise of APAC as a Global Packaging Hub
Pharmaceutical packaging innovation has historically centred on North America and Europe—but that's shifting. APAC now represents roughly 60% of the world's population and ranks as the #2 largest global region for drug delivery devices. Discover the four converging forces reshaping the region: regional collaboration across manufacturing hubs, biologics-driven demand for sterile packaging, the rise of patient-administered drug delivery, and accelerating digital transformation.
Singapore: The Region's High-Value Coordination Hub
Singapore can't compete on manufacturing volume—but it doesn't need to. Explore how the country has carved out a premium niche in biologics, fill-finish operations, clinical-trial supply, and advanced packaging, backed by 25+ free trade agreements, WHO-recognised regulatory credibility, and over US$1.7bn in recent biologics investment from AstraZeneca and AbbVie. With its packaging market forecast to nearly double from US$1.75bn (2024) to US$3.30bn by 2032, learn why Singapore's advantage lies in connectivity and complexity, not scale.
Biologics Are Rewriting Packaging Requirements
As biologics production expands across Singapore, South Korea, China, and Japan, demand is surging for pre-filled syringes, cartridges, high-barrier polymers, and temperature-controlled logistics. Learn how auto-injectors, wearable injectors, and connected delivery devices are becoming standard requirements—and why cold-chain infrastructure is now mission-critical from manufacturing through to the patient.
Smart Packaging and the Digital Manufacturing Shift
Two forces are converging across APAC: rising product complexity and accelerating supply-chain digitalisation. Discover how smart labelling, AI-driven quality control, flexible modular packaging lines, and sustainability initiatives are becoming baseline requirements rather than differentiators.
CDMOs and the Regional Growth Network
With 111 active CDMOs now operating across APAC—39 in India, 30 in China, and 42 across other markets—the region's outsourcing ecosystem has reached critical mass. Explore how packaging demand is increasingly following investment into biologics and specialist manufacturing capability, and why India, China, South Korea, Japan, and Southeast Asia each play distinct, interconnected roles in the region's evolving supply chain.
Pharmapack Asia: Where the Ecosystem Converges
No single organisation delivers modern pharmaceutical packaging alone. See how pharmaceutical companies, CDMOs, packaging suppliers, drug delivery innovators, logistics providers, and regulators are becoming more interconnected—and why Singapore's role as a strategic meeting point positions Pharmapack Asia 2026 as the platform for the next phase of the region's growth.
